MedPath
TGA Approval

OMJJARA momelotinib (as dihydrochloride monohydrate) 150 mg film-coated tablet bottle (442231)

442231

OMJJARA momelotinib (as dihydrochloride monohydrate) 150 mg film-coated tablet bottle

GlaxoSmithKline Australia Pty Ltd

December 18, 2024

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/507a1d93a85d5f9165a596b103784ee2.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/b72e140c5898c61ef33f2e485228901a.pdf

Active Ingredients

momelotinib dihydrochloride monohydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.